| scholarly article | Q13442814 |
| P2093 | author name string | J E Brown | |
| L O Andersson | |||
| P2860 | cites work | Molecular Forms of Antihaemophilic Globulin in Plasma, Cryoprecipitate and after Thrombin Activation | Q71426909 |
| Kinetics of activation of human factor VIII by thrombin | Q71522435 | ||
| Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies | Q72902854 | ||
| Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure | Q34232161 | ||
| Preparation and properties of bovine factor VIII (antihemophilic factor). | Q34285283 | ||
| Factor VIII recombination after dissociation by CaCl12. | Q35110177 | ||
| Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure | Q35199709 | ||
| Some Effects of Calcium on the Activation of Human Factor VIII/Von Willebrand Factor Protein by Thrombin | Q37047369 | ||
| Membrane and lipid involvement in blood coagulation | Q39770485 | ||
| Purification of low molecular weight factor VIII by affinity chromatography using factor VIII - sepharose | Q41592458 | ||
| Von Willebrand factor: dissociation from antihemophilic factor procoagulant activity | Q45890237 | ||
| Studies of the thromboplastic effect of human plasma lipoproteins | Q66844896 | ||
| Importance of protease inhibition in studies on purified factor VIII (antihaemophilic factor) | Q66887242 | ||
| Purification of F.VIII:C by antigen-antibody chromatography | Q67347109 | ||
| The adsorption of coagulation factors onto phospholipids. Its role in the reaction mechanism of blood coagulation | Q68618057 | ||
| Separation of human factor VIII activity from the von Willebrand's antigen and ristocetin platelet aggregating activity | Q68837770 | ||
| Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography | Q70429757 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 161-167 | |
| P577 | publication date | 1981-10-01 | |
| P1433 | published in | Biochemical Journal | Q864221 |
| P1476 | title | Interaction of factor VIII-von Willebrand Factor with phospholipid vesicles | |
| P478 | volume | 200 |
| Q34499164 | A1 subunit-mediated regulation of thrombin-activated factor VIII A2 subunit dissociation |
| Q36447889 | Antihuman factor VIII C2 domain antibodies in hemophilia A mice recognize a functionally complex continuous spectrum of epitopes dominated by inhibitors of factor VIII activation |
| Q54607271 | Autoantibody to factor VIII that has less reactivity to factor Vlll/von Willebrand Factor Complex |
| Q37382199 | B-cell and T-cell epitopes in anti-factor VIII immune responses |
| Q28630980 | Binding of human blood-coagulation Factors IXa and X to phospholipid membranes |
| Q40830151 | Can we improve on nature? "Super molecules" of factor VIII. |
| Q36742268 | Characterization and solution structure of the factor VIII C2 domain in a ternary complex with classical and non-classical inhibitor antibodies |
| Q72167570 | Cleavage of factor VIII light chain is required for maximal generation of factor VIIIa activity |
| Q28630604 | Differential proteolytic activation of factor VIII-von Willebrand factor complex by thrombin |
| Q43792218 | Four hydrophobic amino acids of the factor VIII C2 domain are constituents of both the membrane-binding and von Willebrand factor-binding motifs |
| Q34353691 | Identification of the MMRN1 binding region within the C2 domain of human factor V. |
| Q41017803 | Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor |
| Q37424095 | Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology |
| Q71143329 | Involvement of thrombin anion-binding exosites 1 and 2 in the activation of factor V and factor VIII |
| Q84798069 | Mechanisms of factor VIIa‐catalyzed activation of factor VIII |
| Q34575122 | Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid |
| Q39592850 | Molecular pathology and immunology of factor VIII (hemophilia A and factor VIII inhibitors). |
| Q33962546 | Non-classical anti-factor VIII C2 domain antibodies are pathogenic in a murine in vivo bleeding model. |
| Q36835121 | Nonclassical anti-C2 domain antibodies are present in patients with factor VIII inhibitors |
| Q35818366 | Pathogenic antibodies to coagulation factors. Part one: factor VIII and factor IX. |
| Q51604687 | Phospholipid binding of factor VIII in different therapeutic concentrates. |
| Q42326909 | Proteolytic cleavage of recombinant two-chain factor VIII during cell culture production is mediated by protease(s) from lysed cells. The use of pulse labelling directly in production medium |
| Q74136537 | Recombinant factor VIII SQ--stability of VIII: C in homogenates from porcine, monkey and human subcutaneous tissue |
| Q80273707 | Relationship between the binding sites for von Willebrand factor, phospholipid, and human factor VIII C2 inhibitor alloantibodies within the factor VIII C2 domain |
| Q67780926 | Separation of large unilamellar liposomes from blood components by a spin column procedure: towards identifying plasma proteins which mediate liposome clearance in vivo |
| Q27680123 | Structure of the factor VIII C2 domain in a ternary complex with 2 inhibitor antibodies reveals classical and nonclassical epitopes |
| Q37334275 | The association of factor VIII with von Willebrand factor |
| Q36743356 | The diversity of the immune response to the A2 domain of human factor VIII |
| Q35832756 | The important role of von Willebrand factor in platelet-derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies. |
| Q39591751 | The physiology and pathophysiology of the factor VIII complex |
| Q33729929 | Use of high-resolution techniques for the characterization of clotting factor VIII. |
| Q67912516 | von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation |
Search more.